1. First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.
- Author
-
Chabala, C., Jacobs, T.G., Moraleda, C., Ndaferankhande, J.M., Mumbiro, V., Passanduca, A., Namuziya, N., Nalwanga, D., Musiime, V., Ballesteros, A., Domínguez-Rodríguez, S., Chitsamatanga, M., Cassia, U., Nduna, B., Bramugy, J., Sacarlal, J., Madrid, L., Nathoo, K.J., Colbers, A., Burger, D.M., Mulenga, V., Buck, W.C., Mujuru, H.A., Brake, L.H.M. te, Rojo, P., Tagarro, A., Aarnoutse, R.E., Chabala, C., Jacobs, T.G., Moraleda, C., Ndaferankhande, J.M., Mumbiro, V., Passanduca, A., Namuziya, N., Nalwanga, D., Musiime, V., Ballesteros, A., Domínguez-Rodríguez, S., Chitsamatanga, M., Cassia, U., Nduna, B., Bramugy, J., Sacarlal, J., Madrid, L., Nathoo, K.J., Colbers, A., Burger, D.M., Mulenga, V., Buck, W.C., Mujuru, H.A., Brake, L.H.M. te, Rojo, P., Tagarro, A., and Aarnoutse, R.E.
- Abstract
Contains fulltext : 299969.pdf (Publisher’s version ) (Open Access), Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.
- Published
- 2023